Linda Woodall
Child & Adolescent Psychiatry · Pasadena, CANPI 1477522738
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,488 and has fallen 84.9% since, to $225 in 2025. Among child & adolescent psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$685
- Johnson & Johnson$601
- Takeda Pharmaceuticals U.S.A., Inc.$319
- Sunovion Pharmaceuticals Inc.$300
- Supernus Pharmaceuticals, Inc.$253
- Ironshore Pharmaceuticals Inc.$222
- plus $987 from 15 others
What the payments were for
- Food & beverage$3,368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,368 in reported general payments places this provider in the 90th percentile of 434 child & adolescent psychiatry providers in California.
See all child & adolescent psychiatry providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 25 | $9,643 |
| Duloxetine Hcl | 39 | $1,171 |
| Lamotrigine | 68 | $1,071 |
| Divalproex Sodium | 23 | $815 |
| Quetiapine Fumarate | 15 | $654 |
| Bupropion XlBupropion Hcl | 21 | $394 |
| Escitalopram Oxalate | 16 | $280 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $273 |
| Benztropine Mesylate | 15 | $228 |
| Ziprasidone Hcl | 13 | $148 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $114 |
| Zolpidem Tartrate | 15 | $98 |
| Lorazepam | 20 | $69 |
| Clonazepam | 12 | $62 |
| Fluoxetine Hcl | 14 | $16 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Pasadena
- Daryoush JamalPasadena$13K
- Kevin CoxOjai$2.9M
- Sukhjit BrarFresno$283K
- Manpreet SinghSacramento$104K
- Ihab SolimanCorona del Mar$93K
- Syed NaqviLos Angeles$69K
- Ellen HeynemanSan Diego$62K
- Mark McDonaldLos Angeles$31K
- James HartmanDanville$21K
- Mohsin KhaliqueSan Ramon$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.